why choose us

First received: August 8, 2022

Clinical Trial: Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment

Study Status: Completed

Recruit Status: Completed

Condition: Hepatocellular Carcinoma, Unresectable, Advanced

Study Type: Interventional


Official Title: Phase II Study of Gemcitabine With Oxaliplatin in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment

Brief Summary: The purpose of this study is to test the safety of gemcitabine and oxaliplatin regimen and to see its effects on sorafenib treatment failed hepatocellular carcinoma patients.

Read more